Perceptions and Barriers toward HPV Vaccination among Young Women: A Physiological Perspective
DOI:
https://doi.org/10.63682/jns.v14i15S.3734Abstract
Background: Human Papillomavirus (HPV) infection is the leading cause of cervical cancer worldwide. Young women are underserved and under-immunized within the context of an effective vaccine. Inaccuracies, cultural beliefs, lack of knowledge, and access barriers all lead to low uptake. Knowledge of perceptions and barriers is necessary to steer appropriate health promotion strategies.
Objectives: To review the perceptions, attitudes and barriers on HPV vaccination among young women with some particular attention to different socio-cultural, financial and information factors impacting acceptance and uptake of the vaccine.
Study Design and Settings: A cross-sectional study at Abbasi Shaheed hospital, Karachi, January 2025 to June 2025.
Methods: A cross-sectional study was conducted among 120 young women of age group between 18 and 26 years. A structured questionnaire was used to evaluate sociodemographic information, knowledge, perceptions and barriers about the HPV vaccination. Statistical analyses were conducted using SPSS version 24.0. Continuous variables were expressed as the mean ± standard deviation and categorical, as a percentage. Associations were determined by chi-square and independent t-tests, with significance set at p < 0.05.
Results: The mean age of 120 subjects was 21.8 ± 2.4 years, who were included in the study. The knowledge about HPV infection was acknowledged by 38% of respondents and only 25% had heard about the vaccine. Key barriers included not
knowing about DAA (62%), safety concerns (48%) and cost of DAA therapy (40%). Parental opposition was noted by 30% of the respondents. Women with more than secondary school education were significantly more likely to accept future vaccination (p = 0.02), as well as those who had heard of HPV previously in the bivariate analysis (p = 0.01). Cultural stigma and misinformation were the reasons cited most often for being hesitant to become vaccinated.
Conclusions: Lack of awareness, cultural stigma, safety concern and high cost remain barriers to HPV vaccine uptake among young women. Education and prior knowledge were better predictors of vaccine acceptance. To mitigate these barriers is need for targeted health educational programs, affordability measures and a strong support from the healthcare provider. Attending to sociocultural influences and misinformation will facilitate acceptance and reduce disease morbidity from HPV
Downloads
References
World Health Organization. Human papillomavirus (HPV) and cervical cancer. WHO Fact Sheet. Geneva: World Health Organization; 2024.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49.
National Cancer Institute. HPV and Cancer. Bethesda (MD): National Cancer Institute; 2023. Available from: https://www.cancer.gov.
Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against HPV types 16 and 18. Lancet. 2006;367(9518):1247-55.
World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva: WHO; 2020.
Gallagher KE, LaMontagne DS, Watson-Jones D. Status of HPV vaccine introduction and barriers to country uptake. Vaccine. 2018;36(32):4761-7.
Ortashi O, Shallal M, Osman N, Al-Tajir G, Al-Helou S. Awareness, knowledge, and attitude towards HPV infection and vaccination among women in the UAE. Asian Pac J Cancer Prev. 2013;14(10):6077-80.
Rosen BL, Shew ML, Zimet GD, Ding L, Kahn JA. Attitudes, knowledge, and beliefs regarding HPV vaccination among parents of adolescent girls: a systematic review. Vaccine. 2020;38(19):3242-9.
Pelletier H, Tran T, Laprise JF, Brisson M. Determinants of HPV vaccine hesitancy and acceptability in low- and middle-income countries: a systematic review and meta-analysis. PLoS One. 2022;17(3):e0265288.
Adegboyega A, Choi SK, Vanderpool RC. Beliefs and knowledge related to human papillomavirus (HPV) and vaccination in college students at a public university in Kentucky, USA. Kentucky ScholarWorks. 2019.
University of Kentucky Markey Cancer Center. Human Papillomavirus (HPV) Vaccination in Kentucky: An Environmental Scan. Lexington (KY): University of Kentucky; 2016.
Patel DA, Rosenthal SL, Mehta NR, et al. Human papillomavirus vaccine intent and uptake among female college students. J Am Coll Health. 2012;60(2):151-61.
Hakimi S, Salman S, Najjar S, et al. Barriers to the HPV vaccination program in the Eastern Mediterranean Region: a narrative review. J Turk Ger Gynecol Assoc. 2023;24(3):161-73
Rahman M, Laz TH, Berenson AB. Geographic and demographic disparities in HPV knowledge among young adults. J Womens Health (Larchmt). 2022;31(9):1312-20
Muthukrishnan M, Berenson AB. Barriers to human papillomavirus (HPV) vaccination among young adults in the U.S. Hum Vaccin Immunother. 2022;18(1):2054932.
Zhang S, Vanderpool R, Kiser M, et al. Overcoming barriers to human papillomavirus vaccination in low-resource settings: financial sustainability and health system integration. Vaccine. 2025;43(4):820-8.
Liu CC, Huang WY, Huang JP, et al. School-based intervention strategy to improve HPV vaccination rates among college students: results from a cluster randomized trial. BMJ Open. 2025;15(11):e102235.
Oyedeji O, Akinyemiju T, Islam JY, et al. HPV vaccination behavior among young adults in the United States: a cross-sectional study. PLoS One. 2024;19(11):e0312700.
Tobaiqy M, MacLure K. A systematic review of human papillomavirus vaccination challenges and strategies to enhance uptake. Vaccines (Basel). 2024;12(7):746.
Hamid MK, Hasneen S, Lima AK, Shawon SR, Shahriar M, Anjum R. Cervical cancer trends, HPV vaccine utilization, and screening in low-and lower-middle-income countries: an updated review. Therapeutic Advances in Vaccines and Immunotherapy. 2025 Jul;13:25151355251356646.
Brown AL, Kesselheim AS, Grennan T. Determinants of vaccine hesitancy among young adults in the United States. Vaccine. 2023;41(12):1874-81.
Reiter PL, McRee AL. HPV vaccination among college students: a systematic review. J Am Coll Health. 2023;71(4):1085-94.
Boersma E, Blackwell C, Webb M. Cultural and social barriers to HPV vaccination in university populations. Prev Med Rep. 2024;36:102492.
Fontenot HB, Fantasia HC, Charyk A. Provider recommendation and HPV vaccine uptake among young adults. J Pediatr Adolesc Gynecol. 2023;36(2):149-55.
Holman DM, Benard VB, Roland KB, et al. Barriers to human papillomavirus vaccination among US adolescents: a review of the literature. JAMA Pediatr. 2024;178(1):76-84.
Mills R, Cooper B, Tullos K. Stigma and misconceptions surrounding HPV vaccination in college settings. Health Educ J. 2023;82(7):998-1008
-.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
